Orange Book product · Generic (ANDA)
ARFORMOTEROL TARTRATE
ARFORMOTEROL TARTRATE
At a glance
Nov 15, 2022
Approved
Generic (ANDA)
Application
AN
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 15, 2022
3 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
ARFORMOTEROL TARTRATE
Strength
EQ 0.015MG BASE/2ML
Dosage form
SOLUTION
Route
INHALATION
TE code
AN
Application
ANDA 216128
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of ARFORMOTEROL TARTRATE
- 2006BROVANABrand (NDA)
NDA 021912 · LUPIN
- 2025ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 218429 · SABA ILAC SANAYI
- 2025ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 218555 · MICRO LABS
- 2025ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 218380 · AUCTA
- 2024ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 218156 · LEXENPHARM
- 2024ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 215032 · DR REDDYS
- 2024ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 216303 · NEOCUBES PHARMA
- 2024ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 214901 · AIPING PHARM INC
- 2022ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 216815 · WILSHIRE PHARMS INC
- 2022ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 215385 · SUN PHARM
- 2022ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 214779 · ALEMBIC
- 2022ARFORMOTEROL TARTRATEGeneric (ANDA)
ANDA 214736 · RITEDOSE CORP
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
